A groundbreaking shift in our drug policy has taken place, as the regulators allow the use of psilocybin fungi for therapeutic purposes. Until now, these substances were severely restricted, but a growing body of evidence suggests they potentially offer relief for mental health issues like anxiety. The new policy represents a substantial step towar